Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)

Disease Sites:

Kidney (Renal Cell)

Staging:

Phase III

Age Group:

Both

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Benedetti, Daniel

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

07-10-2025

Trial Type:

Treatment

Protocol ID:

COGAREN2231

National Clinical Trial ID:

NCT06401330

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available